Modification of the 8 drugs in 1 day regimen: feasibility of substitution of other agents

[1]  D. Stewart,et al.  Penetration of teniposide (VM-26) into human intracerebral tumors , 1984, Journal of Neuro-Oncology.

[2]  W. Bleyer,et al.  Eight drugs in one day chemotherapy in children with brain tumors: a critical toxicity appraisal. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  N. Nissen,et al.  Therapy-related acute nonlymphocytic leukemia of FAB type M4 or M5 with early onset and t(9;11) (p21;q23) or a normal karyotype: a separate entity? , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  H. Friedman.  Rational for "eight-in-one" chemotherapy. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  P. Gaynon,et al.  Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report. , 1987, Cancer treatment reports.

[6]  E. Kosnik,et al.  Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  Goldie Jh,et al.  Interaction of etoposide and cisplatin in an in vitro tumor model. , 1987 .

[8]  J. Allen,et al.  Carboplatin and recurrent childhood brain tumors. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  J. A. Jefferies,et al.  Pilot study of cyclophosphamide plus carboplatin in advanced ovarian carcinoma. , 1987, Cancer treatment reports.

[10]  R. Wittes,et al.  Etoposide (VP-16-213). Current status of an active anticancer drug. , 1985, The New England journal of medicine.

[11]  L. Liu,et al.  Role of topoisomerase II in mediating epipodophyllotoxin-induced DNA cleavage. , 1984, Cancer research.

[12]  M. Egorin,et al.  Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function. , 1984, Cancer research.

[13]  M. D’Incalci,et al.  Etoposide (VP-16-213) in malignant brain tumors: a phase II study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.